Rorden Wilkinson
British academic and author
Rorden Wilkinson's AcademicInfluence.com Rankings
Download Badge
Political Science
Rorden Wilkinson's Degrees
- PhD International Relations University of Sussex
- Masters International Relations University of Sussex
- Bachelors Politics University of Sussex
Why Is Rorden Wilkinson Influential?
(Suggest an Edit or Addition)According to Wikipedia, Rorden Wilkinson FAcSS FRSA is a British academic and author. He is Deputy Vice-Chancellor and Professor of International Political Economy at Macquarie University, Sydney, Australia. He was previously Pro Vice-Chancellor and Professor of International Political Economy at the University of New South Wales, Sydney, Australia; Deputy Pro Vice-Chancellor , Professor of Global Political Economy, and a Fellow of the UK Trade Policy Observatory at the University of Sussex; and Professor of International Political Economy and Research Director of the Brooks World Poverty Institute at the University of Manchester. He did his doctoral work and began his academic career at the University of Auckland, New Zealand. He has been a visiting scholar at Brown University, USA, Wellesley College, USA, and the Australian National University.
Rorden Wilkinson's Published Works
Published Works
- Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. (2014) (904)
- AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis (2007) (340)
- Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody (2015) (276)
- Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase. (2007) (251)
- Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery (2016) (242)
- Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade (2017) (234)
- Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530 (2009) (194)
- Rethinking Global Governance? Complexity, Authority, Power, Change (2014) (148)
- CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype (2018) (144)
- Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. (2006) (142)
- Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma. (2013) (134)
- Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. (2001) (113)
- AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer (2010) (107)
- Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies (2019) (98)
- The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models (2012) (98)
- The role of Fc gamma receptors in the activity of immunomodulatory antibodies for cancer (2014) (97)
- Global Governance: Critical Perspectives (2002) (94)
- Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors. (2006) (87)
- Positive selection of thymocytes involves sustained interactions with the thymic microenvironment. (1995) (84)
- AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts (2009) (84)
- AZD1152 rapidly and negatively affects the growth and survival of human acute myeloid leukemia cells in vitro and in vivo. (2009) (77)
- Enhanced apoptosis and tumor growth suppression elicited by combination of MEK (selumetinib) and mTOR kinase inhibitors (AZD8055). (2012) (76)
- The WTO: Crisis and the Governance of Global Trade (2006) (74)
- Collapse at the WTO: a Cancun post‐mortem (2004) (72)
- Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model (2016) (69)
- Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity (2008) (66)
- The Global Governance Reader (2005) (65)
- MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue (2017) (64)
- A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer (2017) (61)
- Epidermal growth factor receptor tyrosine kinase inhibitors: similar but different? (2009) (60)
- Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. (2006) (54)
- Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment (2020) (53)
- Developing country participation in the GATT: a reassessment (2008) (53)
- The Development of an Immunohistochemical Method to Detect the Autophagy-Associated Protein LC3-II in Human Tumor Xenografts (2011) (52)
- Progress in the development of selective inhibitors of aurora kinases. (2005) (51)
- Identification of a developmentally regulated phase of postselection expansion driven by thymic epithelium. (1998) (50)
- Design and efficacy of a monovalent bispecific PD-1/CTLA-4 antibody that enhances CTLA-4 blockade on PD-1+ activated T cells. (2021) (48)
- The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) Enhances the Radiation Responsiveness of Lung and Colorectal Tumor Xenografts (2009) (47)
- Methodological considerations in the development of HPLC-MS methods for the analysis of rodent plasma for metabonomic studies. (2009) (46)
- Colonial Imaginaries and Postcolonial Transformations: exiles, bases, beaches (2010) (45)
- Global Governance to the Rescue: Saving International Relations? (2014) (42)
- A novel systemically administered toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models (2014) (42)
- Language, power and multilateral trade negotiations (2009) (41)
- Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy (2016) (41)
- A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist (2017) (39)
- China and the WTO (2011) (39)
- Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in ApcMin/+ mice (2008) (37)
- China Threat? Evidence from the WTO (2013) (36)
- Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min/+) mouse by (1)H MAS NMR spectroscopy. (2009) (36)
- Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores. (2001) (36)
- Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: selective inhibitors of Aurora B kinase with potent anti-tumor activity. (2008) (36)
- The WTO after Hong Kong: progress in, and prospects for, the Doha Development Agenda (2007) (36)
- The wto in Bali: what mc9 means for the Doha Development Agenda and why it matters (2014) (35)
- Multilateralism and the World Trade Organisation: The Architecture and Extension of International Trade Regulation (2001) (33)
- Rethinking Global Governance (2019) (33)
- Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype (2013) (32)
- What's Wrong with the WTO and How to Fix It (2014) (32)
- The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment (2017) (31)
- Camptothecin prodrug block copolymer micelles with high drug loading and target specificity (2014) (31)
- Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer. (2011) (31)
- Progress in the development of selective inhibitors of Aurora kinases. (2005) (29)
- The WTO in Hong Kong: What it really means for the Doha Development Agenda (2006) (28)
- Labor Standards and Global Governance: Examining the Dimensions of Institutional Engagement (2000) (28)
- The WTO in crisis: exploring the dimensions of institutional inertia (2001) (27)
- MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential (2017) (26)
- The International Labour Standards Regime: A Case Study in Global Regulation (2005) (26)
- Intratracheal and oral administration of SM‐276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer (2013) (25)
- The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment (2017) (25)
- Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro (2020) (25)
- Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent (2017) (24)
- Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy (2016) (24)
- A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers (2007) (24)
- Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade (2018) (24)
- The Globally Governed—Everyday Global Governance (2018) (23)
- The global compact: Promoting corporate responsibility? (2001) (23)
- A mathematical model of antibody-dependent cellular cytotoxicity (ADCC). (2018) (20)
- Humanisation and characterisation of PR1A3, a monoclonal antibody specific for cell-bound carcinoembryonic antigen (1999) (19)
- The Poverty of the Doha Round and the Least Developed Countries (2011) (19)
- The WTO in Nairobi: The Demise of the Doha Development Agenda and the Future of the Multilateral Trading System (2016) (19)
- Expert Knowledge in Global Trade (2015) (19)
- Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker. (2009) (18)
- Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancer (2020) (18)
- What Happened to Doha in Geneva? (2010) (18)
- TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice (2015) (17)
- International Labour Standards and World Trade: No Role for the World Trade Organisation? (1998) (17)
- What’s the point of international relations (2017) (17)
- Heat-damaged red cell scan for intraoperative localization of the accessory spleen. (1994) (16)
- AZD 5438 , a potent oral inhibitor of cyclin-dependent kinases 1 , 2 , and 9 , leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts (2009) (16)
- GLOBAL GOVERNANCE , POVERTY AND INEQUALITY (2010) (15)
- Global governance: a preliminary interrogation (2002) (15)
- Zombies and IR: A Critical Reading (2016) (15)
- Global change, small island state response: restructuring and the perpetuation of uncertainty in Mauritius and Seychelles (2013) (15)
- The Contours of Courtship: the WTO and Civil Society (2002) (15)
- New Labour and the Global Economy (2000) (15)
- Changing power relations in the WTO – Why the India–U.S. trade agreement should make us worry more, rather than less, about global trade governance (2015) (14)
- The Millennium Development Goals and beyond : global development after 2015 (2012) (14)
- The WTO in Buenos Aires: The Outcome and its Significance for the Future of the Multilateral Trading System (2018) (13)
- Global metabolite profiling of human colorectal cancer xenografts in mice using HPLC-MS/MS. (2013) (12)
- A cell-engineered system to assess tumor cell sensitivity to CD8+ T cell-mediated cytotoxicity (2019) (12)
- Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors (2001) (12)
- Crisis in Cancún (2004) (12)
- The Politics and Perils of Plurilaterals (2012) (12)
- Evaluation of a transgenic mouse model for anti-human CEA radioimmunotherapeutics. (2002) (12)
- Radiation Therapy Induces an Adaptive Upregulation of PD-L1 on Tumor Cells Which May Limit the Efficacy of the Anti-Tumor Immune Response But Can Be Circumvented by Anti-PD-L1 (2014) (11)
- Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study (2005) (11)
- Inhibition of Aurora-B kinase activity confers antitumor efficacy in preclinical mouse models of early and advanced gastrointestinal neoplasia. (2012) (11)
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two (2016) (11)
- International Organization and Global Governance (2019) (10)
- Of Butchery and Bicycles: The WTO and the ?Death? of the Doha Development Agenda (2012) (10)
- Reforming WTO-Civil Society Engagement (2017) (10)
- Peripheralising Labour: The ILO, WTO and the completion of the Bretton Woods project (2002) (10)
- The Idea of Global Civil Society: Ethics and Politics in a Globalizing Era (2004) (10)
- Preclinical modelling of immune checkpoint blockade (P2012) (2013) (9)
- Most favoured nation (2005) (9)
- Labour and Trade-Related Regulation: Beyond the Trade-Labour Standards Debate? (1999) (9)
- Extensive sequence and structural evolution of Arginase 2 inhibitory antibodies enabled by an unbiased approach to affinity maturation (2020) (9)
- A transgenic mouse model for tumour immunotherapy: induction of an anti-idiotype response to human MUC1 (2000) (9)
- Change and Continuity in Global Governance (2015) (8)
- Profiling biological samples using ultra performance liquid chromatography-inductively coupled plasma-mass spectrometry (UPLC-ICP-MS) for the determination of phosphorus and sulfur-containing metabolites. (2011) (8)
- Measuring the WTO’s Performance: An Alternative Account (2011) (8)
- Phosphorus and sulfur metabonomic profiling of tissue and plasma obtained from tumour-bearing mice using ultra-performance liquid chromatography/inductively coupled plasma mass spectrometry. (2013) (8)
- A pharmacokinetic–pharmacodynamic model predicting tumour growth inhibition after intermittent administration with the mTOR kinase inhibitor AZD8055 (2017) (7)
- Introduction: concepts and issues in global governance (2005) (7)
- Abstract 2776: MEDI5752: A novel bispecific antibody that preferentially targets CTLA-4 on PD-1 expressing T-cells (2018) (7)
- Regulatory Change and Telecommunications Governance (2002) (7)
- The WTO after Hong Kong (2007) (7)
- Tumor Infiltrating Regulatory T Cells: Tractable Targets for Immunotherapy (2010) (7)
- Past as global trade governance prelude: reconfiguring debate about reform of the multilateral trading system (2018) (7)
- The WTO after Hong Kong: setting the scene for understanding the Round (2007) (7)
- AZD 1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo (2009) (7)
- Trade, Poverty, Development (2012) (6)
- The World Trade Organisation and the Regulation of International Trade (2005) (6)
- Back to the future: ‘retro’ trade governance and the future of the multilateral order (2017) (6)
- The UN and the post-2015 development agenda: from global poverty to "structural transformations" (2014) (6)
- International organization and global governance: what matters and why (2013) (6)
- Preclinical evaluation of M 30 and M 65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity (2008) (6)
- AZD1152: A highly potent and specific aurora kinase inhibitor. (2006) (6)
- China as a System Preserving Power in the WTO (2015) (5)
- The problematic of trade and development beyond the Doha Round (2009) (5)
- Footloose and fancy free? The multilateral agreement on investment (1999) (5)
- Conceptualising Regulatory Change - Explaining Shifts in Telecommunications Governance (2001) (5)
- How the Poor Pay for the US Trade Deficit and Why it Matters for the Doha Development Agenda (2007) (5)
- A rapid method for the analysis of cell proliferation and survival in intestinal adenoma from the Apc(Min) mouse (2001) (5)
- The UK trade landscape after Brexit (2016) (4)
- Abstract 5365: Molecular and pharmacological (EGFRi, MEKi) characterisation of a colorectal cancer (CRC) cell line panel to evaluate cellular phenotype and efficacy of targeted therapies in CRC (2011) (4)
- Abstract 5017: MEDI1191, a novel IL-12 mRNA therapy for intratumoral injection to promote TH1 transformation of the patient tumor microenvironment (2019) (4)
- Brave New World: Global Development Goals after 2015 (2012) (4)
- Reglobalizing trade: progressive global governance in an age of uncertainty (2020) (4)
- What have the poorest countries to gain from the Doha Development Agenda (DDA) (2010) (4)
- Thallium-201 single-photon emission computed tomography imaging in a pediatric brain tumor. A case report. (1991) (4)
- The World Trade Organization (2002) (4)
- Global Change, Small Island State Response: economic restructuring and its consequences in Seychelles and Mauritius (2008) (4)
- Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancer (2021) (4)
- What Kind of Civil Society? The Changing Complexion of Public Engagement at the WTO (2018) (4)
- Introduction - Asking questions of, and about, IR (2017) (3)
- Abstract 561: MEDI1873: A novel hexameric GITRL fusion protein with potent agonsitic and immunomodulatory activities in preclinical systems (2016) (3)
- Changing of the Guard: Expert Knowledge and ‘Common Sense’ in the Doha Development Agenda (2012) (3)
- Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity (2021) (3)
- The anti-tumor immune response generated by radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade (2014) (3)
- Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model. (2010) (3)
- Disrupting traditional pedagogy: active learning in practice (2019) (3)
- China in the WTO (2012) (3)
- Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action (2020) (2)
- 157 The mTOR kinase inhibitor AZD8055 induces cell death in Her2+ tumours partially or intrinsically resistant to ErbB2 inhibitors (2010) (2)
- Global governance, beyond IR? (2016) (2)
- Hegemony, Private Actors, and International Institutions: Transnational Corporations as the agents of transformation of the trade regime from GATT to the WTO (2012) (2)
- Multilateralism and the World Trade Organisation: The Practice of Regulating International Trade (1997) (2)
- Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation (2022) (2)
- Governing the World Trade Organization: Barriers to WTO reform: intellectual narrowness and the production of path-dependent thinking (2011) (2)
- The VEGF receptor tyrosine kinase inhibitor ZD6474 significantly reduces intestinal tumor burden in the Min mouse (2004) (2)
- The Global Compact (2007) (2)
- From international organization to global governance (2018) (2)
- Abstract 1076: Antagonists of the chemokine receptor CCR4 reverse the tumor-promoting microenvironment of renal cancer (2014) (2)
- Abstract 1372: Cediranib alone and in combination with mechanistically distinct antitumor therapies in vivo (2010) (2)
- Governing E-Commerce Prospects and Problems (2003) (2)
- Abstract 289: The combination of CD40 agonism and PD-L1 blockade enhances anti-tumor immunity in a mouse syngeneic orthotopic pancreatic tumor model (2015) (2)
- Introduction: moving from MDGs to GDGs: development imperatives beyond 2015 (2013) (2)
- Abstract 2567: Enhancement of antitumor activity of DSP-6434, a novel TLR7 agonist through reduction of TLR tolerance (2014) (2)
- The “Missing Middle” (2022) (1)
- Governing Global Poverty and Inequality (2010) (1)
- Global Governance, for Whom? (2011) (1)
- The WTO in Bali: What MC9 Means for the Doha Development Agenda and Why it Matters? (2014) (1)
- Fit for Purpose? The Multilateral Trading System and the Post-2015 Development Agenda (2014) (1)
- Introduction: Drivers and Change in Global Governance (2015) (1)
- THE FUTURE OF UK-US TRADE: AN UPDATE (2019) (1)
- Global Governance Futures (2021) (1)
- What needs to be done before we reform the WTO (2012) (1)
- Reconciling Regionalism and Multilateralism in the International Trading System (1998) (1)
- Normalising Empire, Ignoring Imperialism (2005) (1)
- Continuity and change in global governance: a normative quest (2015) (1)
- Continuity and change in global governance (2015) (1)
- Africa and the MDGs:: Challenges and Priorities (2012) (1)
- 'Emerging' powers and the governance of global trade (2014) (1)
- Plus ça change? Business as usual in the governance of global trade: Business as usual in the governance of global trade (2013) (1)
- Global Governance, for whom? A response to Lamy (2011) (1)
- 469 POSTER Detection of surrogate markers of apoptosis in the peripheral blood of a preclinical tumour model treated with a selective inhibitor of Aurora B kinase (AZD1152) (2006) (1)
- Abstract 5034: The antitumor immune response generated by radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade (2014) (1)
- Abstract 4697: Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment and holds potential for combination with immune checkpoint inhibitors (2017) (1)
- Research data supporting "Optoacoustic detection of early therapy-induced tumor cell death using a targeted imaging agent" (2017) (1)
- Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models (2021) (1)
- Abstract 1475: Local immune activation resulting in tumor growth inhibition with MEDI9197 - an intratumorally administered TLR7/8 agonist (2016) (1)
- AZD2171, an orally active inhibitor of VEGFR tyrosine kinase activity, reduces polyp burden in a mouse model of intestinal cancer (2005) (1)
- Immune mediated therapy and MEK inhibition: preclinical assessment of immunobiology and combination activity in vitro and in vivo (2014) (1)
- 265 POSTER A MEK1/2 inhibitor, AZD6244 (ARRY-142886), shows beneficial effects when combined with standards of care or novel therapies – mechanistic characterisation suggests a role for apoptosis (2008) (1)
- Abstract 3820: Novel PD-1/GITRL bispecific fusion protein delivering concurrent T cell co-stimulation and checkpoint pathway inhibition (2018) (1)
- 160 Antitumor therapy with VEGF receptor tyrosine kinase inhibitor ZD6474 in a mouse model of intestinal cancer (2004) (1)
- Abstract 4556: MEDI5395: An armed oncolytic Newcastle disease virus (2017) (1)
- Abstract 6535: A recombinant Newcastle disease virus expressing IL-12 has potent pre-clinical immunomodulatory and anti tumor properties (2020) (1)
- Inhibition of VEGFR reduces polyp burden in the APC (min/+) mouse model of intestinal cancer (2006) (1)
- The combination of melphalan with prednisolone (1981) (1)
- The Specific Aurora Kinase Inhibitor AZD1152 Significantly Affects the Growth of Human Leukaemic Cells in an In Vivo AML Model. (2006) (1)
- Activity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in combination with standard and approved therapies: impact of in vivo sequencing of drug administration (2008) (1)
- Abstract 4987: Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and reduce response to immuno-oncology treatments (2019) (0)
- Abstract 4186: Syngenomic fingerprint: the biomic characterization of the mouse syngeneic tumor models (2016) (0)
- A mouse GITRl fusion protein drives T cell activation and antitumor activity in preclinical mouse models of cancer (2015) (0)
- Abstract 4902: A mouse GITRL fusion protein drives T-cell activation and antitumor activity in preclinical mouse models of cancer (2016) (0)
- Vandetanib inhibits both pVEGFR2 and pEGFR at clinically achievable drug levels in preclinical models (2007) (0)
- Abstract 4613: Identification of tumor necrosis factor receptor II as a regulatory T cell target for cancer immunotherapy using designed ankyrin repeat protein phenotypic selections (2014) (0)
- Abstract 1584: Efficacy and pharmacodynamic effect of anti-CD73/PD-L1 monoclonal antibodies in combination with chemotherapy: Observations from mouse tumor models (2021) (0)
- Abstract 4750: Maximising the activity of immune checkpoint blockade through rational combination. (2013) (0)
- Abstract 4434: Combined targeting of Aurora B (AZD1152) and MEK1/2 (AZD6244) kinases leads to enhancement of anti-tumour effectsin vivo. (2010) (0)
- Abstract 1190: Tissue slice culture platform: A slice of reality in drug development (2019) (0)
- Adaptive resistance to fractionated radiation therapy can be overcome by concurrent PDL1 blockade (2014) (0)
- Abstract A13: Characterization of CRC primary explant models in comparison to standard human tumor cell-line-derived CRC xenografts. (2011) (0)
- Introduction (2021) (0)
- 497 Combination therapy with an Aurora B kinase inhibitor AZD1152 and AraC, shows enhanced tumouricidal activity in a preclinical model of acute myeloid leukaemia (AML) (2010) (0)
- Abstract B300: Discovering immune-mediated therapy for cancer biologics is informed by in vitro cellular assays. (2013) (0)
- Abstract 270: Preclinical assessment of combination therapy with selumetinib and CTLA-4 for cancer (2015) (0)
- Abstract 4604: MEDI1873, a GITR ligand fusion protein (GITRL FP), induces effector T-cell proliferation, modulates T-regulatory cell function and has the potential to combine with checkpoint inhibitors (2017) (0)
- Abstract 1133: A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression (2023) (0)
- The WTO After Hong Kong: Prospects for, and progress in the Doha Development Agenda (2007) (0)
- Abstract 711: Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies (2018) (0)
- Global governance: change and continuity (2015) (0)
- Elevated stromal Foxp3+ regulatory T cells combined with low density CD8+ cytotoxic T cells are associated with colorectal metastatic tumour progression (2011) (0)
- Thymic Epithelium Phase of Postselection Expansion Driven by Identification of a Developmentally Regulated (1998) (0)
- Revisiting WTO Reform (2019) (0)
- Abstract 2152: Characterisation of co-expression of CD39 with other IO-relevant markers on major T/NK cell TIL subsets (2020) (0)
- Novel pyrazole- and thiazole-substituted quinazolines as potent aurora kinase inhibitors. (2006) (0)
- Governing E-commerce Prospects and Problems Governing E-commerce Prospects and Problems * (2003) (0)
- The WTO in Crisis. Exploring the Dimensions of Institutional Inertia (2001) (0)
- What Kind of Civil Society? Debating Trade at the WTO Public Forum (2017) (0)
- Abstract 1451: Analysis of expression MHC class I chain-related gene A and B (MICA/B) in normal and tumor tissue (2016) (0)
- Culture, Ethnicity and Human Rights in International Relations (1997) (0)
- Tissue slice culture platform: A slice of reality in drug development (2019) (0)
- Global Governance and the WTO (2007) (0)
- Introduction (2021) (0)
- Family Dramas: politics, diplomacy and governance in the WTO (2008) (0)
- Recasting Labor Diplomacy (2001) (0)
- China and the WTO, Redux: Making Sense of Two Decades of Membership (2022) (0)
- Multilateralism and the WTO: Extending the parameters of trade regulation? (2005) (0)
- 617 POSTER In vivo evaluation of efficacy and pharmacodynamic biomarkers of AZD0530, a dual-specific Src/Abl kinase inhibitor, in preclinical, subcutaneous xenograft models (2006) (0)
- China and the WTO 中国与世贸组织 James Scott and Rorden Wilkinson (2011) (0)
- Actores del “sector medio desconocido”. La gobernanza global entre bastidores (2022) (0)
- PO-370 A co-culture assay system using engineered anti-CD3 tumour cells to assess tumour cell sensitivity to CD8 +T cell killing (2018) (0)
- Book reviews (2000) (0)
- Inhibition of VEGFR reduces polyp burden in a mouse model of intestinal cancer (2006) (0)
- AZD6244 (ARRY-142886), a potent and highly selective MEK1/2 inhibitor, demonstrates anti-HIF properties, and increases the therapeutic response in a lung tumor xenograft model when combined with radiotherapy (2007) (0)
- New Zealand, Indonesia and East Timor: what next? (1995) (0)
- The World Trade Organisation (2006) (0)
- Introduction (2021) (0)
- THE FUTURE OF US-UK TRADE WHAT CASE FOR A BILATERAL TRADE AGREEMENT ? (2018) (0)
- The Political Economy of International Economic Law (2002) (0)
- Making sense of global governance futures (2021) (0)
- Barriers to WTO Reform: intellectual narrowness and the production of path dependent thinking: Intellectual narrowness and the production of path dependent thinking (2011) (0)
- The institutional evolution of international trade regulation (2005) (0)
- Multilateralism: The architecture of international trade regulation (2005) (0)
- 52. Development of a human CEA transgenic mouse model (2001) (0)
- Dispute settlement and the WTO (2005) (0)
- Book Review: Stephen Chan, Towards a Multicultural Roshamon Paradigm in International Relations (Tampere. Finland: Tampere Peace Research Institute, 1996), pp. 150 (1998) (0)
- 'Gridlock? Maybe' [Review] Thomas Hale, David Held and Kevin Young (2013) Gridlock: Why global cooperation is failing when we need it most (2016) (0)
- Global Trade Governance: the WTO at a crossroads (2006) (0)
- The promise of "development" and the Doha Development Agenda (2012) (0)
- Abstract 1663: CD40 agonists drive the anti-tumor functions of macrophages and induce systemic immune activation survival the Pan02 orthotopic pancreatic model (2014) (0)
- Book Review: Ken Booth and Steve Smith (eds.), International Relations Theory Today (Cambridge: Blackwell, 1995), pp. xii, 367, $39.95 (1996) (0)
- MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue (2017) (0)
- Crisis in Canc?n (2016) (0)
- Abstract 821: B7-H3 is a potential antibody drug conjugate target for the treatment of prostate cancer (2018) (0)
- Abstract 4203: Non-invasive imaging of tumor cell death induced by a TRAILR2 agonist (2016) (0)
- Abstract C2: Selection for combinational studies through biomarker stratification in colorectal patient-derived explant models. (2011) (0)
- First-mover preferences, structural power and path dependancy : the World Trade Organisation and e-commerce (2003) (0)
- Conclusions: Emerging Powers in the wto – Beware the Glass Ceiling (2016) (0)
- Non-discrimination and the WTO (2005) (0)
- Quantitative assessment of tumour infiltrating lymphocytes using GenieTM pattern recognition software for the separate analysis of tumour versus stroma in head and neck squamous cell carcinoma (HNSCC) improves biomarker reproducibility (2011) (0)
- Precise determination of toll-like receptor (TLR) 7 expression in multiple human tumor types (2014) (0)
- Multilateral trade and the post 2015 development agenda (2015) (0)
- Abstract 2866: Volumetric optoacoustic imaging of tumor cell death using a targeted imaging agent (2017) (0)
- Working Paper # 5 October 2011 China and the WTO 中国与世贸组织 (2011) (0)
- AZD1152, a selective inhibitor of Aurora B kinase, induces growth arrest and apoptosis in intestinal tumor models (2007) (0)
- The WTO, the UN, and the Future of Global Development (2020) (0)
- Trade barrier reduction and the WTO (2005) (0)
- Abstract 389: The dual mTOR inhibitor, AZD2014, and castration increase intra-tumoral immune cell infiltration and anti-tumour activity in a genetically engineered mouse model of prostate cancer (2016) (0)
- Miscellaneous: P22: The value of automated cellular imaging on tissue microarrays in the drug-discovery process (2009) (0)
- ZD6474 can significantly reduce polyp burden in a mouse model of intestinal cancer (2005) (0)
- Abstract 1651: Profiling immune cells within the tumor microenvironment for optimal model selection for pre-clinical investigations (2014) (0)
- Abstract 3765: An anti-CD137 antibody can show greater efficacy in syngeneic mouse tumor models when combined with other immuno-oncology (IO) therapies (2018) (0)
- 471 Inhibiting signalling by erbB receptor tyrosine kinases with AZD8931, a potent reversible small molecule inhibitor, reduces intestinal adenoma formation in the ApcMin/+ mouse model (2010) (0)
- Abstract 1758: Intratumoral IL-12 mRNA promotes cytotoxic T cell-dependent anti-tumor immunity and enhances responses to PD-L1 blockade in pre-clinical models (2018) (0)
- Abstract 2571: Sustained induction of TRAIL and granzyme B as well as intratumor infiltration of cytotoxic T lymphocytes (CTL) by a novel TLR7 agonist, DSR-6434, after systemic administration (2014) (0)
- Building Asymmetry: Concluding the DDA (2007) (0)
- Deep phenotyping of surface stimulatory and inhibitory co-receptors on cancer-resident T and NK cells reveals cell subsets within the tumor-reactive CTL population that are uniquely defined by NKG2A expression. (2021) (0)
- P03.13 Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and reduce response to immune-oncology treatments (2020) (0)
- IN VIVO IMAGING OF THE HUMAN THYROID WITH THE RUTHERFORD POSITRON CAMERA USING I-124 (1982) (0)
This paper list is powered by the following services:
Other Resources About Rorden Wilkinson
What Schools Are Affiliated With Rorden Wilkinson?
Rorden Wilkinson is affiliated with the following schools: